Tuesday - September 22, 2026
Menopause expert can discuss newly FDA-approved non-hormonal hot-flash drug
October 27, 2025
EVANSTON, Illinois, Oct. 27 -- Northwestern University posted the following news release:

* * *

Menopause expert can discuss newly FDA-approved non-hormonal hot-flash drug

*

* Hot flashes are linked to insomnia, heart disease, weight gain, sexual dysfunction, bone loss

* Newly approved drug decreases hot flashes by an average of 67%

* Elinzanetant 'comes out ahead' of other FDA-approved non-hormonal drug . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products